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  i 
Abstract 
This matched case-control study examined the association between environmental heat 
exposure and hospital encounters with acute kidney injury (AKI) among adults, 66 years 
and older, in the province of Ontario, Canada. We matched 52,913 cases who had an AKI 
event during the warm seasons (April to September) of 2005 to 2012 with 174,222 
controls who did not have an AKI event. We matched cases to controls on date, age, sex, 
residential status, income, and history of chronic kidney disease using a variable one to 
four matching ratio. We classified heat periods as three consecutive days where the 95th 
percentile of area-specific daily maximum temperature was reached or exceeded. We 
determined associations using conditional logistic regression. Compared to non-heat 
periods, high heat periods were significantly associated with greater risk of AKI (adjusted 
odds ratio 1.11, 95% confidence interval 1.00 to 1.23).  
Keywords 
Acute kidney injury, administrative data, case-control, environmental heat, maximum 
temperature, Ontario 
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Chapter 1  
1 Introduction 
Climatological research strongly indicates that green house gas emissions are 
contributing to the warming of the Earth’s surface.1 There is near unanimous consensus 
that climbing temperatures will coincide with more frequent and severe heat waves.2 This 
is alarming as the loss of life attributed to heat events is of considerable magnitude.3 
Unmitigated environmental heat has also been repeatedly demonstrated to induce multi-
organ morbidity,4 with the  kidneys appearing particularly vulnerable.5,6 The volume 
contractions that accompany environmental heat may lead to the short-term loss of 
kidney function.7 Acute kidney injury (AKI) is the medical term for this loss of function.8 
AKI is a serious health condition and its occurrence is associated with increased risk of 
chronic kidney disease, reduced quality of life, and death.9–12 Older adults may be 
disproportionately impacted by heat-associated AKI as a result of declining 
thermoregulatory abilities,13,14 and age-based declines in kidney function.15  
 
In previous studies environmental heat has been shown to consistently and significantly 
exacerbate the risk of AKI across the United States and Australia.16–25 However, the 
generalizability of the association between environmental heat and AKI to more northern 
latitudes has not been adequately investigated. Moreover existing studies have lacked 
outcome focus and methodological rigor. To remedy these knowledge gaps, we 
performed a matched case-control study with the purpose of evaluating the association 
between environmental heat and hospital encounters with AKI among older adults in 
Ontario, Canada.  
 
The remainder of this thesis is structured into the following chapters: 2 Literature review, 
3 Objectives, 4 Methods, 5 Results, and 6 Discussion. In Chapter 2 we describe what 
constitutes environmental heat and review effect modifiers of heat health relationships as 
well as risk factors for heat-related illness. This is followed by an explanation of what 
constitutes AKI and the salient risk factors for AKI. Finally, we bring the two together to 
explore what is known of the association between environmental heat and AKI. In 
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Chapter 3 we explicitly state the objectives of our research project. In Chapter 4 we 
provide a transparent and detailed summary of our methods. In Chapter 5 we present our 
written results and accompanying figures and tables. Lastly, in Chapter 6, we discuss our 
findings, contextualizing them within the current literature and touching briefly on their 
implications. We also reflect on the strengths and weaknesses of our work and conclude 
with suggestions for future research.  
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Chapter 2 
2 Literature review 
2.1 Environmental heat  
Rising ambient temperatures threaten to endanger human health. In conducting this 
literature review we classified environmental heat as high ambient temperatures 
originating from natural weather variation experienced at any time of day. This broad 
definition of environmental heat may at times overlap and be compounded by aspects of 
occupational heat, which can also originate from natural sources. However, occupational 
heat is distinct in that it sometimes can stem exclusively from industrial sources and is 
typically confined to the hours that workers are on the job (e.g. boiler room staff, 
firefighters).26  
 
Environment Canada once provided an official, country-wide definition of a heat wave as 
three or more consecutive days when the maximum temperature was ≥32oC.27 However, 
that definition is no longer in use and has been replaced by region-specific definitions of 
heat events. Within the province of Ontario, Canada the maximum temperatures for 
declaring heat alerts range between 29oC to 31oC depending on the location.28 In many 
parts of Ontario, the number of days reaching above 30oC between 2021-2040 is 
predicted to double compared to those observed between 1961-1990.29 With high heat 
periods expected to become more frequent, detriments to public health are likely 
imminent.30,31  
2.2 Effect modifiers of heat-health relationships and risk 
factors for heat-related illness 
Vulnerability to environmental heat is not uniform. Age, biological sex, comorbidities, 
medications, residential status, and socioeconomic status may modify heat-health 
relationships (third level variable) and/or directly alter the risk of heat-related illness 
(independent variable). 
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2.2.1 Age 
Age is a prominent modifier of the relationship between heat and mortality. In August 
2003, a heat wave struck France resulting in roughly 15,000 excess deaths, the majority 
of which were concentrated among the community-dwelling elderly. 32 Increased age also 
appears to negatively modify the relationship between heat and morbidity.14,33 One study 
out of New South Wales showed that for those aged 75 and older, the risk of all-cause 
emergency department visits increased by 8% (relative risk [RR] 1.08, 95% confidence 
interval [CI] 1.04 to 1.11) during heat waves, verses an increase of 1% (RR 1.01, 95% CI 
1.00 to 1.02) in the under 75 age group.14 A formal statistical test for interaction by age 
group was not performed.14  
Several risk factors for heat-related mortality occur more frequently with older age as the 
human body’s ability to withstand environmental heat declines.34 During periods of 
dehydration, elderly individuals demonstrate impaired thirst recognition as well as 
diminished conservation of sodium and water.19 On top of thermoregulatory deficiencies, 
a lack of mobility may compound heat susceptibility.35 Being bed-bound (odds ratio [OR] 
6.4, 95% CI 4.5 to 9.2), not leaving the home on a daily basis (OR 3.6, 95%CI 1.6 to 6.9) 
and the inability to administer self care (OR 3.0, 95%CI 1.8 to 4.8) have all been 
identified as prognostic factors associated with increased odds of death during heat 
waves.36 
2.2.2 Biological sex 
Evidence for whether biological sex modifies heat-health relationships is conflicting and 
may be outcome dependent. Some studies have identified increased heat-related 
morbidity in males,37–39 explicitly for cardiovascular outcomes such as stroke,40 and acute 
myocardial infarction.41,42 Yet, other studies have identified increased heat-related 
mortality in females. 32,43–46 Whether biological mechanisms underscore these observed 
sex differences in morbidity and mortality is poorly understood.40 It is also possible that 
the observed sex differences are derived from behavioral discrepancies (e.g. likelihood to 
engage in outdoor activities).38 Alternatively, the supposed sex differences may be a 
statistical byproduct. For instance, the higher suggested heat-related mortality in females 
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may result from residual confounding. Based on natural age structures and longer life 
expectancies, older segments of the population are often comprised of greater proportions 
of females.43 Moreover in studies that do not control for income, it is possible that age 
and sex act as proxies for socioeconomic status. Therefore, effect estimates may differ in 
relation to the specific control variables included within the statistical models of each 
study.  
2.2.3 Comorbidities  
The impact of environmental heat on human health should be assessed in accordance 
with comorbidity status, which can both modify heat-health relationships and serve as a 
direct risk factor for heat-related illness.  
 
Diabetes has been shown to act as an effect modifier intensifying susceptibility to heat 
stress. Hallmark features of diabetes such as poor glucose control, changes in insulin 
kinetics and diabetic neuropathy may adversely impact heat tolerance.47 In diabetics, the 
ORs for mortality during episodes of extreme heat, compared to non-heat episodes, range 
from 1.01 to 1.17.48,49  
 
Deaths during heat waves have also been associated with the following risk factors: pre-
existing psychiatric illness (OR 3.6, 95% CI 1.3 to 9.8), cardiovascular illness (OR 2.5, 
95% CI 1.3 to 4.8), and pulmonary illness (OR 1.6, 95% CI 1.2 to 2.1).36 
2.2.4 Medications 
Certain medications appear to be potent risk factors for morbidity and mortality during 
heat spells. Medications have the potential to interfere with adaptive heat responses by 
antagonizing water retention, reducing heart rate, blocking autonomic input, curtailing 
sweat production, hampering visceral blood flow, and decreasing renal function.50 
Despite the vast potential for harm, there is limited evidence linking medication use to 
heat-related morbidity and mortality.  
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Psychotropic drugs seem to be especially hazardous during times of high heat since their 
actions on neuronal inputs can interfere with heat dissipation.50 During the Western 
European August 2003 heat wave, the use of any psychotropic drug was associated with a 
29% (95% CI 22% to 37%) increase in risk of death for elderly individuals aged 70 to 
100 years.51 Moreover, there was a significant dose-response relationship between the 
number of psychotropic drugs and risk of death (adjusted OR for linear trend 1.25, 95% 
CI 1.21 to 1.29), with the highest effect estimates found for antidepressants (adjusted OR 
1.71, 95% CI 1.57 to 1.86), and antipsychotics (adjusted OR 2.09, 95% CI 1.89 to 
2.35).51 Another study that focused on hospital admissions during the same 2003 heat 
wave yielded analogous main effect estimates.52 The meta-analysis by Bouchama et al. 
reinforced the dangers, demonstrating that psychotropic drug use during heat waves 
increased the pooled odds of death almost two-fold (OR 1.9, 95% CI 1.3 to 2.8).36  
2.2.5 Residential status 
The built environment and human activity alter surface temperature conditions. The 
urban heat island is an example of this, whereby air temperatures in metropolitan regions 
are elevated in comparison to surrounding non-metropolitan regions.53 Temperatures in 
urban centers have been recorded to be between 2oC to 12oC higher than in nearby rural 
areas.54 Urban heat islands are the culmination of many factors such as loss of vegetation 
cover, sparse tree canopies, increased anthropogenic gases, and reduced ventilation.54,55 
Pervasive dark sealed surfaces in urban areas also disrupt energy balances and interfere 
with nocturnal cooling so that nighttime temperatures stay elevated. Under these 
conditions, reprieve from the heat is limited. 56,57 Previous studies have found heat-health 
effect estimates are modified by geographic region with more urban districts showing the 
largest associations for mortality.56,58,59 
In addition to having distinct physical landscapes, urban centers also exhibit high 
settlement densities. Population density is a risk factor for heat stress with greater 
densities achieved by residents dwelling in closer proximities.60 Living on the upper 
floors of high rise apartment buildings has also been demonstrated to aggravate heat-
related morbidity.61,62  
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Although not subject to urban heat islands or high settlement densities, rural settings are 
still vulnerable to environmental heat stress for different reasons. Firstly, the catchment 
areas for rural hospitals tend to be larger, meaning residents may have to travel further to 
access care.63 Secondly, distinct lifestyle differences between urban and rural residents 
persist. A Canadian study looking at daily time-activity patterns demonstrated that rural 
seniors (aged 60 and over) spent on average 0.9 more hours outdoors per day compared 
to urban seniors (p-value<0.001).64 Overall, rural residents were less likely to have an air 
conditioner (43.0% vs. 57.2 %, p-value<0.001).64 Furthermore, 37.8% (95% CI 31.2% to 
44.4%) of rural residents reported working in outdoor occupations verses only 23.1% 
(95%CI 19.0% to 27.2%) of urban residents.64 Urbanites may be protected in this regard, 
given that time spent indoors is significantly associated with lower personal heat 
exposure.65 
In the past, investigations specific to rural communities have been scarce because 
meteorological monitors in these locations are usually spaced far apart. A contemporary 
study used geostatistical kriging to interpolate heat stress and found the average rate of 
emergency room visits in rural Southern, Ontario (defined as communities of <100,000 
population) was 1.11 times higher (95% CI 1.07 to 1.15) during a heat wave than during 
control periods.63 As temperature modeling systems continue to improve, it is critical to 
consider the unique challenges faced by rural communities in juxtaposition to their urban 
counterparts.  
2.2.6 Socioeconomic status 
Socioeconomic status has been shown to modify temperature-health relations.66,67 Lower 
SES has also been implicated as a risk factor for heat-related illness.68,69 A study of the 
1980 heat wave in St. Louis and Kansas City, United States found age-adjusted rates of 
heatstroke were six-fold higher in the lowest SES quartile compared to the highest SES 
quartile.68 Correspondingly, during the 2009 heat wave in Adelaide, Australia, hospital 
admissions for heat-related illness more than doubled for individuals in the lowest SES 
quartile compared to individuals in the other quartiles (OR 2.10, 95% CI 1.09 to 4.04).69 
Poor quality housing and lack of access to air-conditioning are circumstances that are 
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believed to contribute to the observed increases in heat-related morbidity and mortality in 
individuals of low SES.70  
2.3 Acute kidney injury 
Acute kidney injury (AKI) was formerly referred to as acute renal failure. In conducting 
this literature review, AKI was used exclusively and was considered to encompass the 
more narrowly defined acute renal failure.  
AKI is a serious clinical condition characterized by an abrupt decline in kidney 
function.71 AKI is classified along a spectrum of pathology, ranging from mild to severe, 
and occurs over a continuum of time, spanning from hours to days.72 A cornerstone of 
AKI is the build-up of serum creatinine (SCr) and other nitrogenous waste products in 
response to diminishing glomerular filtration rates (GFR).73 In the majority of patients, 
the deterioration in kidney function is also followed by a decrease in urine output.74 
Based on the most recent consensus guidelines, AKI can be diagnosed if one of the 
following criteria is fulfilled: (I) SCr increase ≥ 0.3 mg/dl (≥ 26.5 µmol/l) within 48 
hours; or (II) a ≥1.5-fold SCr increase within seven days (as compared to a known or 
suspected baseline value); or (III) a reduction in urine output to < 0.5 ml/kg/day for at 
least 6 hours.8 
To date, epidemiological research has focused on well-defined cases of hospital-acquired 
AKI. However, information on the frequency of community-acquired AKI is integral to 
understanding external risk factors. One study that managed to quantify community-
based rates, observed that when comparing 1996-1997 to 2002-2003 the incidence of 
non-dialysis requiring AKI in the general population rose from 323 (95% CI 317 to 329) 
to 522 (95%CI 516 to 529) per 100,000 person years; while the incidence of more severe 
dialysis-requiring AKI rose from 20 (95%CI 18 to 21) to 30 (95%CI 28 to 31) per 
100,000 person years.75 Although AKI-associated mortality has decreased in the last few 
decades in developed countries, the absolute number dying remains high because of 
increasing incidence.76,77 
AKI is estimated to afflict over 13 million people each year, placing a tremendous burden 
on individual patients and international health-care systems at large.78 AKI is more 
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common in the elderly79 and has been associated with significant mortality, development 
of end-stage renal disease (ESRD), longer hospital stays, and inflated health care 
costs.9,10 There are few proven therapies to reverse the damage of AKI. Acute dialysis is 
the standard therapeutic option, but is not a direct treatment. Dialysis merely supplants 
kidney function to allow time for healing. Even if the patient survives, full restitution of 
kidney function is not guaranteed and depends in part on age, pre-existing disease, and 
the extent of structural damage.80,81  
2.4 Risk factors for acute kidney injury 
Age, biological sex, chronic kidney disease, diabetes, cardiovascular disease, liver 
disease, and certain medications have all been identified as risk factors for AKI.  
2.4.1 Age 
Increasing age is associated with increasing risk of AKI. Older adults are more 
susceptible to AKI for several reasons; 1) increased prevalence of comorbidities, such as 
diabetes and heart failure; 2) higher rates of diagnostic procedures and medical 
interventions;82 and, 3) increased use of medications that either directly injure the kidneys 
or indirectly interfere with the kidneys’ regulatory capacities.79 
Further compounding the vulnerability of older adults are anatomical and physiological 
problems with the kidneys themselves. Age-based structural impairments include 
decreases in total renal mass, glomerulosclerosis, vessel wall thickening, and tubule 
loss.12 Functionally, these impairments translate into natural declines in GFR, usually 
beginning in the fourth decade of life (30 to 39 years of age).15,83 
It is probable that the rising incidence rates of AKI are tied to aging population 
structures.75,84,85 Community-based incidence rates of AKI have been observed to 
increase from 815 per 100,000 person-years (95%CI 801 to 828) in those aged 60 to 69, 
to 1809 per 100,000 person-years (95% CI 1784 to 1835) in those aged 70 to 79, all the 
way up to 3545 per 100,000 person-years (95%CI 3481 to 3610) in those aged 80 and 
over.75  
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The high incidence of AKI in older adults is concerning given the poor prognoses for 
members of this population. In a meta-analysis of 17 studies published between 2000 and 
2007, it was shown that 31% of patients with AKI aged 65 and older were unable to 
return to baseline kidney function or regain independence from renal replacement 
therapy, compared to 26% of patients under age 65 (pooled RR 1.28, 95% CI 1.06 to 
1.55).80 
2.4.2 Biological sex 
Males appear to be more susceptible to AKI than females.75,84,86 A study investigating 
community-acquired AKI out of Canada, observed the annual incidence of severe AKI to 
be 13 per 100,000 in males compared to 9 per 100,000 in females (RR 1.4, 95% CI 1.1 to 
1.9).86 For those aged 65 and older, the sex difference was even greater with 70 per 
100,000 males affected verses 32 per 100,000 females (RR 2.2, 95% CI 1.5 to 3.2).86 
Additional work is needed to explain the underpinnings of these reported sex-differences 
in AKI risk. 
2.4.3 Chronic kidney disease 
Chronic kidney disease (CKD) is defined by a baseline GFR of <60 ml/min/1.73m2 
persisting for more than 3 months.87 It is distinguished from AKI by its longevity. 
Despite having different timescales, the two conditions are closely interrelated.88 
Research in this area has shown a graded relationship between progressive CKD stages 
(lower estimated GFR categories) and escalating risk of AKI.89,90 A study from 1996 to 
2003, found the adjusted ORs for dialysis-requiring AKI were 2.0 (95% CI 1.7 to 2.3), 
6.5 (95% CI 5.6 to 7.7), 28.5 (95% CI 24.5 to 33.1), and 40.1 (95% CI 33.8 to 47.6) 
comparing hospitalized adults with respective baseline estimated GFRs of 45-59, 30-44, 
15-29, and <15 ml/min/1.73m2 to a non-CKD referent group with estimated GFRs ≥ 60 
ml/min/1.73m2.89 An ensuing Canadian study from 2003 to 2006 found congruent results; 
adjusted ORs for AKI were 2.9 (95% CI 2.7 to 3.1), 6.2 (95% CI 5.7 to 6.8), and 18.3 
(95% CI 16.5 to 20.3) comparing hospitalized adults with baseline estimated GFRs of 45-
59, 30-44, and <30 ml/min/1.73m2 to a non-CKD referent group with estimated GFRs 
≥60 ml/min/1.73m2. 90 
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2.4.4 Diabetes 
Diabetes is a potent risk factor for the development of AKI.91,92 In diabetes, the inability 
to produce insulin leads to high blood glucose levels that progressively scar renal 
vasculature and heighten susceptibility to acute insults. A population-based study of 
adults in a Health Region of Alberta, Canada estimated the risk of severe community-
acquired AKI to be 10.3 times higher in individuals with diabetes compared to those 
without (RR 10.3, 95% CI 7.7 to 13.6).86 A case-control study comparing a sample of 
hospitalized patients also demonstrated an association between hospital-acquired AKI 
and diabetes, though the effect was dampened (adjusted OR 2.1, 95% CI 1.9 to 2.3).89 
2.4.5 Cardiovascular disease 
There is a reciprocal relationship between heart failure and worsening kidney function. 
The two adverse outcomes often occur concomitantly with the failing heart accelerating 
kidney under-perfusion, and vice-versa.93 A meta-analysis of 80,098 heart failure patients 
classified 63% as having any renal impairment, with 29% having modest to severe 
impairment.94 The adjusted all-cause mortality was significantly elevated in heart failure 
patients with any renal impairment (hazard ratio [HR] 1.56, 95% CI 1.53 to 1.60) and 
modest to severe renal impairment (HR 2.31, 95% CI 2.18 to 2.44) compared to heart 
failure patients without renal impairment.94  
Beyond heart failure, other cardiovascular conditions may also predispose to AKI. Severe 
AKI has been found to develop more frequently among individuals with a history of heart 
disease (RR 24.0, 95% CI 18.5 to 31.2) or stroke (RR 22.0, 95% CI 15.6 to 31.0).86 AKI 
requiring dialysis has also been found to develop more frequently among hospitalized 
adults with diagnosed hypertension.89 
2.4.6 Liver disease 
AKI is a potential sequela of liver disease, occurring in up to 20% of hospitalized patients 
with cirrhosis.95 An analysis of intensive care-units in 16 countries found patients with a 
history of cirrhosis were more than twice as likely to develop AKI than patients without a 
history of cirrhosis (OR 2.18, 95% CI 1.16 to 4.10). 96 Development of AKI in patients 
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with compromised liver function is an important prognostic factor, predicting increased 
morbidity and mortality.97–100 
2.4.7 Medications 
Modulations in renal blood flow may trigger AKI. Three classes of drugs with the 
capacity to induce AKI through hemodynamically mediated pathways are: 
1) diuretics; 2) non-steroidal anti-inflammatory drugs (NSAIDs); and, 3) angiotensin-
converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs).101,102 
Diuretics deplete fluid volumes and are known to increase AKI risk.103,104 A multi-center 
prospective study identified diuretics as the second-leading cause of drug-induced AKI 
accounting for 22% of cases.104 
NSAIDs have also been associated with increased AKI risk.105 NSAIDs inhibit 
prostaglandin production, which results in reduced dilation of the afferent arterioles in the 
kidneys. When renal perfusion is inadequate, the NSAID-invoked limitations on intra-
renal blood flow may lead to kidney damage.101 A meta-analysis of five observational 
studies found that AKI risk was significantly elevated among traditional NSAID users in 
comparison to non-users, with the pooled RRs for individual NSAIDs varying between 
1.58 and 2.11.105 The association between NSAIDs and AKI is of concern due to the 
widespread access and ubiquitous use of these drugs.106  
Other frequently prescribed drugs that have been associated with increased AKI risk are 
ACE inhibitors and ARBs. These drugs exert antihypertensive effects by interfering with 
the production and binding of angiotensin-II. However, by disrupting the renin-
angiotensin system, ACE inhibitors and ARBs simultaneously limit the body’s ability to 
compensate for volume losses.107 An ecological study in England approximated that up to 
15% of the escalation in AKI admissions detected from 2007 to 2011 were attributable to 
increases in ACE inhibitor and ARB prescribing rates.108 
Diuretics, NSAIDs, and ACE inhibitors or ARBs may be even more dangerous when 
taken in combination. A nested case-control study followed 487,372 antihypertensive 
users for a mean of 5.9 years to show that triple therapy was associated with a 31% 
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increase in AKI risk (RR 1.31, 95% CI 1.12 to 1.53) when compared to use of 
antihypertensive drugs (diuretics and/or ACEis or ARBs) without NSAIDs.109 A 
subsequent nested case control study of 78,379 antihypertensive users, also found that 
triple therapy was associated with increased AKI risk (adjusted rate ratio 1.64, 95% CI 
1.25 to 2.14) when compared to use of antihypertensive drugs without NSAIDs.110 
2.5 Association between environmental heat and acute 
kidney injury  
We performed a detailed literature search of several bibliographic databases and 
identified 10 studies that examined the association between environmental heat and AKI. 
All of the studies (depicted in Table 2-1) found a significant association between various 
heat indicators and increased risk of AKI.16–25 However, these studies were limited by 
outcome measures with unknown or unmentioned validity,16–19,21–25 exclusive use of 
coarse weather station data,16–20,22,24,25 and case-only designs that did not incorporate 
external controls.16–25 In addition, the heat indicators were not chosen with the specific 
etiology of AKI in mind because the majority of these studies set out to explore a 
plethora of heat-related outcomes.16,18–21,23–25 Only two of these studies were focused on 
renal disease.17,22 Moreover, the effect estimates were consistently small in magnitude. 
Although small effect sizes are commonplace in environmental epidemiology,111 in light 
of the limitations of these studies, it is difficult to discern whether the hypothesized heat 
and AKI association is a true effect or merely an artifact of uncontrolled confounding.  
 
Furthermore, over half of these studies were confined to California16,18,19,21,24 and 
Australia.22 California is situated along the Pacific coast of the United States, and as a 
result, has a Mediterranean-like climate with hot, dry summers and mild winters.112 
While in Australia, the temperature threshold for defining heat events tends to be 
considerably higher than in the northern hemisphere.113 The relationship between 
environmental heat and the risk of AKI has not been adequately explored in regions with 
more fluctuating temperature profiles. This is an important step because these regions 
have a very different overall temperature experience due to tremendous variation between 
long cold winters and short summers. For example in Ontario, Canada , winter 
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temperatures can drop below -40oC; while summer temperatures can exceed 30oC.114 
Although consistent hot temperatures are usually confined to June, July, and August, hot 
episodes can also occur anomalously in the late spring and early fall months.115 Taken 
together, the short summers and anomalous heat events may hinder adaptation thereby 
altering the relationship between environmental heat and AKI in Ontario compared to 
other settings.  
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Table 2-1. Summary of key findings associating environmental heat with AKI 
Author, 
Year 
Location, 
Timeframe 
Population 
(Outcome 
Definition) 
Exposure Key Findings Limitations Quality 
Score 
(0-281) 
Time-Stratified Case-Crossover Studies 
Basu et al., 
201216 
California, 
United States, 
May-September, 
2005-2008 
21,650 
emergency room 
visits with 
principal 
diagnosis of 
AKI 
(ICD-9: 584) 
Same day mean 
apparent 
temperature 
- Odds of emergency 
room visit with AKI 
increased 15.9% per 
5.6oC increase in same 
day mean apparent 
temperature (OR 1.159, 
95% CI 1.127 to 1.193) 
- Ecologic-level 
exposure data  
(weather station data, 
with 10 km radius) 
- No information on 
pre-existing illness  
- Possible deviations 
from linearity not 
accounted for 
18 
Fletcher et 
al., 201217 
New York State, 
United States, 
July-August, 
1991-2004 
12,370 
hospitalizations 
with a principal 
discharge 
diagnosis of 
AKI  
(ICD-9: 584) 
Daily mean, 
maximum, and 
minimum values 
of actual and 
apparent 
temperatures, 
lagged by up to 
5 days before 
admission 
- Odds of hospitalization 
with AKI increased 9% 
per 2.78oC in mean 
actual temperature at lag 
1 (OR 1.09, 95% CI 
1.07 to 1.12) 
- Lags 0-2 showed 
significant increases in 
odds of hospitalization 
with AKI across all six 
temperature indicators 
- Ecologic-level 
exposure data 
(weather stations) 
- No information on 
mitigating resources  
- Failed to capture less 
severe illness that did 
not require inpatient 
admission  
 
 
18 
16 
 
 
Green et al., 
201018 
California, 
United States, 
May-September, 
1999-2005 
17,778 hospital 
admissions with 
a primary 
diagnosis of 
AKI  
(ICD-9: 584) 
Same day mean 
apparent 
temperature 
- Odds of hospital 
admission with AKI 
increased 7.4% per 5oC 
increase in same day 
mean apparent 
temperature (OR 1.074, 
95% CI 1.040 to 1.109)  
- Ecologic-level 
exposure data 
(weather stations with 
10 km radius) 
- No information on 
mitigating resources  
- Do not know validity 
of coding practices 
across hospitals and 
diagnoses 
 
18 
Ostro et al., 
201019 
California, 
United States, 
May-September, 
1999-2005 
34,878 hospital 
admissions with 
a primary 
diagnosis of 
AKI  
(ICD-9: 584) 
Mean, 
maximum, and 
minimum daily 
apparent 
temperature 
- Odds of hospital 
admission with AKI 
increased 10.2% per 5oC 
increase in same day 
mean apparent 
temperature (OR 1.102, 
95% CI 1.072 to 1.132) 
- Ecologic-level 
exposure data 
(weather stations) 
- Seasonal and long-
term effects in 
exposure series 
minimized but not 
eliminated  
18 
Time-Series Analyses 
Bobb et al., 
201420 
United States, 
1999 to 2010 
12,676 
hospitalizations 
with AKI in 
adults aged 65 
years or older, 
identified by 
Heat wave 
periods defined 
as at least two 
consecutive days 
with average 
daily 
- RR of hospitalizations 
with AKI increased to 
1.14 (95% CI 1.06 to 
1.23) on heat-wave days 
compared to matched 
non-heat wave days 
- Ecologic-level 
exposure data 
(weather stations 
within 35 km from 
geometric center of 
county)  
20 
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clinical 
classification 
software 
algorithm based 
on ICD-9 codes 
temperatures 
exceeding the 
99th percentile of 
the distribution 
of daily 
temperatures for 
that county 
- Absolute risk 
differences was 0.24 
(95%CI 0.09 to 0.39) 
excess daily hospital 
admissions with AKI 
per 100,000 individuals 
- Wide variety of 
outcomes, multiple 
testing 
Guirguis et 
al., 201421 
California, 
United States, 
May-September, 
1999-2009 
An average of 
57 
hospitalizations 
with diagnosis 
of AKI 
observed per 
non-heat day 
(ICD-9: 584) 
Heat events 
defined as 
periods where 
daily maximum 
temperatures 
and morbidity 
were strongly 
correlated and 
both metrics 
showed 
anomalies 
- Average daily excess 
hospitalizations with 
AKI increased by a 
count of 4.5 (95% CI 
4.4 to 4.5) when 
considering the entire 
span of the heat health 
event and by a count of 
10.1 (95% CI 9.9 to 
10.3) at heat wave peak 
compared to non-heat 
days 
- Ecologic-level 
exposure data 
(weather station data 
interpolated onto a 12 
km x 12 km grid)  
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Hansen et 
al., 200822 
Metropolitan 
Area of 
Adelaide, 
Australia, 
January 1,1995 -
December 31, 
2006 
 
3579 admissions 
with discharge 
diagnosis of 
AKI  
(ICD-10: N17)  
Heat waves 
defined as three 
or more 
consecutive days 
with daily 
maximum 
temperatures 
≥95th percentile  
- IRR of hospital 
admissions with AKI 
increased to 1.255 (95% 
CI 1.037 to 1.519) 
during heat wave 
periods compared to 
non-heat wave periods 
in the warm season 
- Ecologic-level 
exposure data (single 
weather station) 
- No information on 
mitigating resources  
- Possibility of 
miscoding 
- Relatively small 
17 
18 
 
 
(35oC) of 
maximum 
temperature 
range for study 
period 
(November-March) number of admissions  
- No medication 
histories 
- Insufficient control 
of time trends  
Isaksen et 
al., 201523 
King County, 
Washington,  
United States, 
May-September, 
1999-2010  
- 752,151 
unplanned, non-
traumatic total 
hospital 
admissions  
- Number of 
hospital 
admissions with 
the specific 
diagnosis of 
AKI not 
specified 
(ICD-9: 584) 
- RR analysis: 
heat day defined 
as day average 
humidex 
exceeded 99th 
percentile of all 
days, January-
December  
(36.2 oC) 
- Time-series: 
cut-off defined 
as 1.2oC above 
99th percentile  
(37.4 oC) 
- RR of unplanned, non-
traumatic 
hospitalizations with 
AKI increased to 1.68 
(95% CI 1.41 to 2.01) 
on a heat day compared 
to a non-heat day 
-Time-series: For every 
1oC in daily maximum 
humidex above 37.4oC, 
hospitalizations with 
AKI increased by 7.6% 
(95%CI 3.2% to 12.2%) 
- Ecologic-level 
exposure data 
(gridded [1/16°] 
resolution)  
- No information on 
mitigating resources  
- Inappropriate 
boundary selection  
- No correction for 
multiple comparisons 
19 
Case-Only Analyses 
Knowlton et 
al., 200924 
California, 
United States, 
July-August, 
2006 
- 13,829 
hospitalizations 
with a diagnosis 
of AKI recorded 
across any 
diagnostic field  
Heat wave 
period defined 
as July 15 to 
August 1, 
reference 
periods defined 
- RR of hospitalization 
with AKI increased to 
1.11 (95% CI 1.08 to 
1.15) during heat wave 
periods compared to 
non-heat wave periods 
- Limited to a single 
heat wave 
 
19 
19 
 
 
(ICD-9: 584) as July 8-14 and 
August 12-22 
Semenza et 
al., 199925 
Chicago, 
United States, 
July 1994,  
July 1995 
- 61 inpatient 
admissions with 
a primary 
discharge 
diagnosis of 
AKI observed 
during heat 
wave  
(ICD-9: 584), 
only 13 
admissions were 
expected 
Heat wave 
period defined 
as July 13-19 of 
1995, expected 
counts averaged 
across four 
referent weeks 
including July  
6-12 of 1995 
and July 6-12, 
13-19, 20-26 of 
1994  
- 49 (95% CI: 31 to 66) 
excess inpatient 
admissions with a 
primary discharge 
diagnosis of AKI during 
the heat wave compared 
to reference periods 
- Failed to capture less 
severe illness that did 
not require inpatient 
admission  
- Small sample size 
 
14 
Abbreviations: AKI, acute kidney injury; CI, confidence interval; ICD-9 International Classification of Diseases, ninth revision; ICD-10, International 
Classification of Diseases, tenth revision; IRR, incidence rate ratio; OR, odds ratio; RR, relative risk 
1 We evaluated the quality of individual studies using the Black and Downs quality assessment checklist, which is a list of 27 criteria to evaluate both randomized 
and non-randomized trials.116 This scale covers the completeness/clarity of study reporting, external validity, internal validity (e.g. bias and confounding) and 
power. The tool was modified slightly for our use. Specifically, question 27 was simplified to a choice of awarding either 1 or 0 points depending on whether 
there was sufficient statistical power to detect a clinically important effect. We gave all included studies a score from 0 to 28, according to the following four 
quality categories: excellent (26 to 28), good (20 to 25), fair (15 to 19), and poor (less than or equal to 14). 
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2.6 Conclusion 
Environmental heat is recognized as the most common cause of weather-related fatalities 
in high-income countries.117 However, the non-fatal effects of environmental heat are 
underrepresented in the literature.118 One biologically plausible outcome that mandates 
further attention is the development of AKI. Knowledge of the heat and AKI association 
among older adults in Ontario,Canada is imperative because heat exposure is 
avoidable.119 Public health action plans, that direct residents to cooling stations and issue 
heat alerts, may be strengthened by a more thorough understanding of what types of 
services are needed and for whom.  
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Chapter 3 
3 Objectives 
The following objectives pertain to the population of older adults, 66 years and older, 
residing in Ontario Canada.  
3.1 Objective 1 - Costing 
To describe the median 30-day government payer health care cost of a hospital encounter 
with AKI. 
3.2 Objective 2 – Impact of heat periods 
To evaluate whether heat periods are associated with AKI.  
We hypothesize that heat periods will be associated with a higher risk of AKI.  
3.3 Objective 3 – Impact of high humidex periods 
To evaluate whether high humidex periods are associated with AKI. 
We hypothesize that high humidex periods will be associated with a higher risk of AKI.   
3.4 Objective 4 – Effect modification by age 
a) To evaluate whether the association between heat periods and AKI differs between 
individuals aged 66 to 79 years versus those over 79 years.  
We hypothesize that the association between heat periods and risk of AKI will be 
elevated in individuals over 79 years compared to individuals aged 66 to 79 years. 
 
b) To evaluate whether the association between high humidex periods and AKI differs 
between individuals aged 66 to 79 years versus those over 79 years.  
We hypothesize that the association between high humidex periods and risk of AKI will 
be elevated in individuals over 79 years compared to individuals aged 66 to 79 years. 
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3.5 Objective 5 – Evaluation of methodological approaches 
a) To explore whether the association between heat periods and AKI is robust to different 
methodological approaches.  
We hypothesize that the association between heat periods and AKI will be consistent 
across methodological approaches.  
 
b) To explore whether the association between high humidex periods and AKI is robust 
to different methodological approaches.  
We hypothesize that the association between high humidex periods and AKI will be 
consistent across methodological approaches.  
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Chapter 4 
4 Methods 
4.1 Study design 
We conducted a population-based, matched case-control study of older adults, aged 66 
years and over, using Ontario’s linked health care administrative databases. These 
datasets were linked using unique encoded identifiers and analyzed at the Institute for 
Clinical Evaluative Sciences (ICES).  
This study was approved by the institutional review board at Sunnybrook Health Sciences 
Centre, Toronto, Canada. We followed a pre-specified analysis plan and adhered to the 
REporting of studies Conducted using Observational Routinely-collected health Data 
(RECORD) guidelines.120  
4.2 Study population 
Ontario is Canada’s most populous province. As of July 1, 2012, it was estimated that 
approximately 2 million (15%) of Ontario’s roughly 13.5 million residents were aged 65 
years and over, while more than 0.5 million (4%) of the total population were over 79 
years of age.121 All Ontario residents’ receive universal access to hospital and physician 
services under a single-payer health care system. However, individuals aged 65 years and 
over also receive universal outpatient prescription drug coverage. Therefore, we restricted 
our study to Ontario residents aged 66 years and over to ensure at least one year of 
complete information on all dispensed drugs was available and could be included in our 
analysis. Additionally, this age segment mandates specific attention because they are at 
increased risk of heat illness34 and AKI.79  
4.3 Timeframe and setting 
The eight accrual periods of this study spanned from April 1st to September 30th of each 
year from 2005 to 2012. We selected this timeframe because 2005 to 2012 were the only 
years for which heat exposure data were available across the entire warm seasons. We 
defined the warm seasons as April 1st to September 30th in order to capture the wide 
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range of high temperatures experienced across Ontario in a given year. Ontario has a 
humid continental climate typified by large seasonal variations; it is hallmarked by a 
general temperature gradient that decreases moving from north to south and is tempered 
by large bodies of water, especially the Great Lakes.122 Although June, July, and August 
tend to be the hottest months with maximum temperatures exceeding 30oC, outlier heat 
events can occur in the late spring and early fall. As of 2009, over 70% of Ontario 
households had access to an air conditioning unit.123   
4.4 Data sources 
Administrative databases are compilations of digitized data generated whenever health 
care is delivered.124 For instance, the date and time of patient appointments will often be 
logged in a computerized system, as will any compensation claims made by physicians. 
This creates digital footprints that can be linked to follow individual patients as they 
navigate pathways of treatment. Although administrative data are not primarily collected 
for research purposes, when used appropriately the data provide a fertile ground for 
performing research.  
Our study used a combination of administrative, clinical, survey, and weather data. In 
total, we used seven databases to ascertain health outcomes, medication use, patient 
characteristics, temperature exposures, and other covariate information.  
 
1) Registered Persons Database (RPDB) 
RPDB catalogues demographic information and vital statistics for any individual 
who has been issued a health card number in Ontario. We used RPDB to identify 
age, sex, and vital status information. RPDB also contains the best-known annual 
postal code of residence for eligible persons as of July 1st each year. Postal codes 
are six character strings defined for mailing purposes. At the time of this study, 
there were over 280,000 postal codes in Ontario.125 
 
 
25 
 
 
2) Census 
The dissemination area (DA) is the smallest geographic region for which all 
census data relevant to our study are released; approximately 400 to 700 persons 
reside within each DA.126 We retrieved DA-level information on residential status 
(rural vs. urban) and neighbourhood income quintile. We employed an ICES 
definition to classify rural areas as those with a community size ≤10,000. Income 
quintiles were categorized according to fifths of average neighborhood income. 
These quintiles are constructed separately for each census metropolitan area, 
census agglomeration, or residual area before being aggregated to the provincial 
level.127 Consequently, the exact numerical values defining each quintile vary. We 
instead used adjectival descriptors for the quintiles with 1 corresponding to the 
lowest (poorest) quintile and 5 corresponding to the highest (richest) quintile. 
3) Global Environmental Multiscale Surface (GEM-SURF) Database 
GEM-SURF is an external forecasting system developed by Environment Canada. 
The system accounts for land cover (e.g. built or natural) to accurately model 
surface and near-surface meteorological variables with high resolution. In 
previous studies, GEM-SURF weather predictions were shown to improve upon 
existing methods.128–130  
The 2006 census defined 19,177 DAs in Ontario. The GEM-SURF database at 
ICES has daily weather summaries for 19,094 of these DAs. The missing DAs 
were removed from GEM-SURF because they either had incomplete daily 
weather summaries or their central grid points corresponded to bodies of water. 
For the remaining DAs, we used daily weather summaries expressed as 
percentiles of maximum temperature and maximum humidex. These percentiles 
were specific to each DA and were created from the entire timespan of available 
GEM-SURF data (June 1, 2004 to April 30, 2013).  
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4) Canadian Institute for Health Information Discharge Abstract Database (CIHI-
DAD) 
CIHI-DAD contains diagnostic and procedural information for all hospital 
inpatient admissions in Ontario. Up to 25 diagnostic codes can be attributed by a 
medical coder to a single hospitalization, while procedural codes are entered as 
needed. One of the diagnostic codes must be labeled ‘M’ to indicate the condition 
that was most responsible for the length of stay and resources used. Prior to 2002, 
diagnostic codes followed the International Classification of Diseases, Ninth 
Revision (ICD-9) and procedural codes followed the Canadian Classification of 
Diagnostic, Therapeutics, and Surgical Procedures (CCP). From 2002 onward, 
diagnostic codes followed the International Classification of Diseases, Tenth 
Revision (ICD-10) and were accompanied by a new standard of procedural codes, 
the Canadian Classification of Health Interventions (CCI). We used diagnostic 
and procedural codes from these various classification systems to classify 
comorbidity status using a five-year look back window. Since our accrual period 
began in 2005, we used ICD-10 codes exclusively to identify cases with AKI. 
Costing information was also obtained from CIHI-DAD. 
5) Canadian Institute for Health Information National Ambulatory Care Reporting 
System (CIHI-NACRS) 
CIHI-NACRS contains diagnostic and procedural information for all emergency 
department visits that have occurred in Ontario. Up to 10 diagnostic codes can be 
attributed by a medical coder to a single emergency department visit. One of the 
diagnostic codes is referred to as the main diagnosis to indicate the predominant 
impetus driving the patient’s visit and need for treatment. We used CIHI-NACRS 
to complement CIHI-DAD in identifying cases of AKI. We also obtained costing 
information from the CIHI-NACRS database.  
6) Ontario Drug Benefit (ODB) Database 
All Ontario residents aged 65 and older qualify for coverage under the ODB 
program. Written claims for outpatient prescription drugs dispensed under this 
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program are reliably transmitted to the ODB database. Each electronic claim in 
the ODB database accurately identifies the unique drug dispensed, patient to 
whom the drug was dispensed to, prescribing physician, date drug was dispensed, 
number of days supplied, cost, and location of dispensing. The overall error rate 
for electronic information in the ODB database compared to written prescription 
information is 0.7% (95% CI 0.5% to 0.9%).131 We used the ODB database to 
identify long-term care facility utilization and medication use. 
7) Ontario Health Insurance Plan (OHIP) Database 
This database houses information on all health care providers who submit claims 
under OHIP, and includes data on inpatient and outpatient physician services. We 
used the claims information captured in OHIP, in addition to diagnostic and 
procedural information from CIHI-DAD, in identifying comorbidity status. We 
also obtained costing information from the OHIP database.  
These databases, with the exception of GEM-SURF, have been used repeatedly to study 
the outcome of AKI.132–135  
4.5 Data linkage and missingness 
We linked individual records across datasets using unique, encoded personal identifiers 
called ICES Key Numbers (IKNs). We then used the Postal Code Conversion File 
provided by Statistics Canada to convert best annual postal codes of residence, available 
for each individual record, to the corresponding DA.136 This allowed us to link 
geographic attributes (from Census and GEM-SURF) to the IKNs using the assigned DAs 
as the common element.  
We were not able to convert the best annual postal code of residence to the corresponding 
DA in <0.5% of individuals. Without an identifying DA, we could not link area-level 
census attributes including residential status and neighbourhood-level income quintile. 
Instead, we excluded cases and controls missing these attributes prior to matching. 
Moreover, we were not able to link heat exposure information in <0.5% of individuals 
because, as stated in Section 4.4, some DAs are missing form the GEM-SURF database. 
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We excluded cases and controls with missing heat exposures after matching to allow for a 
complete case analysis. Both of these exclusions are detailed in Figure 4-1 (cases) and 
Figure 4-2 (controls). Information on all other variables was complete. 
4.6 Identification of hospital encounters with acute kidney 
injury 
We defined hospital encounters with AKI by the presence of ICD-10 code N17, across 
any diagnostic field in either the CIHI-DAD or CIHI-NACRS databases (see Appendix 
B). In a former validation study, we tested the ‘all diagnoses’ N17 coding algorithm for 
the ability to detect a ≥ 2-fold increase in serum creatinine (SCr) concentration from 
baseline in Ontario’s 66 and over population.137 The sensitivity was found to be 61.6% 
(95% CI 57.5% to 65.5%) for hospital admissions and 37.4% (95% CI 32.1% to 43.1%) 
for emergency department visits; however in both of these settings, the specificity was 
over 95%.137 For hospital admissions, the median absolute change in SCr was 98 µmol/l 
(interquartile range [IQR] 43 to 200) in code positive patients and 6µmol/l (IQR -4 to 20) 
in code negative patients.137 For emergency department visits, the median absolute 
change in SCr was 133µmol/l (IQR 62 to 288) in code positive patients and 2 µmol/l 
(IQR -8 to 14) in code negative patients.137 Although the incidence of AKI may be 
underestimated by up to five-fold using the N17 code, the code does clearly distinguish 
between groups of patients and is more likely to pick up the most severe cases of AKI, as 
defined by greater elevations in SCr.  
4.7 Selection of cases and controls 
We selected all Ontario residents who had at least one hospital encounter (hospital 
admission [CIHI-DAD] or emergency department visit [CIHI-NACRS]) with AKI during 
the study period from April 1st, 2005 to September 30th, 2012 and who were at least 66 
years of age at the time of the encounter. If persons had more than one hospital encounter 
with AKI during the study period, we restricted our analysis to the first encounter. We 
selected the first encounter during the study period in an attempt to identify incident AKI 
cases because it is well established that the initial occurrence of AKI alters the risk of 
recurrence.138,139 However, we were not able to rule out AKI encounters that occurred 
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prior to April 2005. For inpatient admissions we considered the entire hospitalization as 
one encounter, even if the patient was hospitalized at multiple facilities. We excluded 
patients whose first encounter with AKI during the study period fell outside of the 
relevant accrual windows (April 1st to September 30th of each year). For the remaining 
cases, we designated the date of the hospital encounter as the index date.  
 
We defined potential controls as all individuals who met the eligibility of cases, but did 
not have a hospital encounter with AKI over the study period. We randomly selected 
index dates for controls to match the distribution of index dates by cases, so that the 
relative frequency of every day was equally represented across the two datasets. We 
eliminated controls who did not meet the age restriction or had died prior to their selected 
index dates.  
 
The following exclusions applied to both cases and controls: 
 
1) Receipt of dialysis in the year prior to index date, or, receipt of kidney transplant 
in the five years prior to index date.  
The development of AKI was not considered relevant in patients whose kidneys 
were already failing.  
 
2) Long-term care facility utilization prior to index date.  
It was assumed residents’ exposures to ambient temperatures would be limited in 
these climate-controlled facilities.  
The coding definitions for these exclusions are listed in Appendix A.  
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Figure 4-1. Selection of cases 
 
Abbreviations: AKI, acute kidney injury; CIHI, Canadian Institute for Health Information; DAD, Discharge 
Abstract Database; NACRS, National Ambulatory Care Reporting System; n, number; RPDB, Registered 
Persons Database 
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Figure 4-2. Selection of controls   
 
Abbreviations: IKN, ICES Key Number; n, number; RPDB, Registered Persons Database 
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4.8 Matching 
There was an abundance of eligible controls in comparison to eligible cases. Hence, we 
attempted to match up to four controls with each case. We selected four controls 
wherever possible in an effort to increase statistical power.140 We chose to use a variable 
ratio as opposed to a fixed ratio because we planned to match on several factors and we 
did not want to discard valuable case information if a full set of four controls could not be 
matched. We used a greedy method of matching without replacement. After a match was 
made, it was never broken.  
We matched on characteristics thought to be associated with heat exposure and/or AKI 
risk. We matched controls to cases on exact index date, since heat exposure changes over 
time; age (±2 years), since increased age amplifies AKI risk and may impact likelihood 
of heat exposure;79 age group (66 to 79 years, over 79 years), to facilitate a preplanned 
stratified analysis; sex, since males tend to exhibit greater risk of AKI;75,86 urban or rural 
residential status (population, >10,000 or ≤10,000) since residential status may increase 
risk of AKI and modify heat exposure,64,65 income (categorized into fifths of average 
neighborhood income), since lower income may increase risk of heat exposure and 
AKI,17,141,142 and history of CKD, since this condition increases risk of AKI.89,90 We used 
the cohort of cases and controls produced from this initial methodological approach in 
conducting all analyses unless explicitly stated otherwise.   
4.9 Exposure 
There is tremendous heterogeneity in the exposure measures used to examine heat-health 
relationships. Many studies have used iterations of daily mean actual temperatures143–148 
and maximum actual temperatures149,150 for their primary analyses. Whereas other studies 
have used daily mean apparent temperatures16,18,46 or maximum apparent temperatures.151 
Apparent temperature combines the effects of dry temperature and humidity to serve as 
an index of human discomfort. 151,152 Overall, no single exposure measure stands out as 
the best predictor of heat-related mortality across geographic regions and age groups.152 
Rather, the chosen exposure measure tends to reflect practical challenges pertaining to 
particular investigations.  
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We chose to use daily maximum actual temperature to define our primary exposure and 
daily maximum humidex to define our secondary exposure because these indices are easy 
to interpret. They are also the same measures employed by public health authorities in 
Ontario when issuing heat alerts. The daily maximum is the highest actual temperature 
reached in a given DA over a 24-hour period, starting at 12:00 am midnight. Actual 
temperature is measured independent of the moisture content in the air, and for this 
reason we chose to explore humidex in a secondary analysis. Humidex was designed by 
Canadian meteorologists to describe how hot weather feels.152 Akin to apparent 
temperature, the humidex is unitless and integrates temperature and dew point to 
characterize discomfort. A humidex of 30 to 39 is generally associated with some 
discomfort; a humidex ≥40 is associated with great discomfort.153   
 
We expressed daily maximum actual temperatures and daily maximum humidexes as 
percentiles. We derived each set of percentiles based on the entire ranges of daily 
temperatures and humidexes recorded in each DA from June 1st, 2004 to April 30th, 2013. 
We created 19,094 sets of temperature percentiles and 19,094 sets of humidex percentiles 
corresponding to the 19,094 DAs in the GEM-SURF database. We were driven to use 
DA-specific percentiles based on the notion of acclimatization. By using percentiles we 
were able to define environmental heat relative to what individuals were physically 
accustomed to, a practice that has been substantiated elsewhere.143,145,154 
Major findings suggest that the impacts of environmental heat on acute health outcomes 
are quite immediate. In past studies, a consistent three-day lag structure (lag 02) has 
emerged in the relationship between environmental heat and AKI.33,113,146,155 The short 
delay between heat exposure and AKI is physiologically consistent with body water loss 
over time and disrupted fluid balances from dehydration.7 Consequently, we chose to 
implement a three-day lag structure in our study. Day 0 was defined as the index date, 
day 1 was directly before the index date, and day 2 was two days before the index date.  
The relationship between temperature and health outcomes tends to follow a “U”, “V”, or 
“J”-shape with morbidity rapidly escalating beyond certain thresholds.46,145,147–150 We 
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chose to dichotomize our exposures using the 95th percentile as our relative threshold. 
Our decision to use the 95th percentile as the cut-point was motivated by existing 
literature.40,113,156 We chose to dichotomize our exposures rather than model them as 
continuous moving averages because we did not anticipate that the change in risk would 
be the same for each stepwise increase in temperature. We also avoided continuous 
moving averages because our intent was to study sustained high heat without allowing an 
exceptionally hot day to skew the mean. Although ordinal exposures measures would 
have allowed examination of non-linearity and possible dose-response relationships, we 
decided against them because we expected heat effects to be confined to the extreme end 
of the exposure scale157 and foresaw small cell sizes in upper percentile categories as a 
limiting factor.158  
We defined heat periods as three consecutive days (lag 0 [index], lag 1, and lag 2) where 
the 95th percentile of daily maximum actual temperature was reached or exceeded. This 
was our primary measure of environmental heat. We classified cases and controls that did 
not meet the definition of a heat period as being unexposed.    
We defined high humidex periods as three consecutive days (lag 0 [index], lag 1, and lag 
2) where the 95th percentile of daily maximum humidex was reached or exceeded. This 
was our secondary measure of environmental heat. We classified cases and controls that 
did not meet the definition of high humidex periods as being unexposed.   
4.10 Covariate adjustment 
We consulted nephrologists and reviewed the literature in order to identify non-
intermediary variables believed to be causally associated with AKI. We sought to adjust 
for these variables in our analysis to correct for different predispositions to AKI among 
cases and controls. In the five years prior to index date a history of diabetes, congestive 
heart failure, coronary artery disease excluding angina, stroke, peripheral vascular 
disease, chronic liver disease, and hypertension were identified for adjustment (Appendix 
C); in the 120 days prior to index date evidence of prescriptions for angiotensin-
converting enzyme (ACE) inhibitors alone, angiotensin II receptor blockers (ARB) alone, 
ACE inhibitors and ARBs together, potassium-sparing diuretics, nonpotassium-sparing 
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diuretics, non-steroidal anti-inflammatory drugs (NSAID) excluding aspirin, and 
psychotropics were identified for adjustment.36,86,89,93,100,101,109,110,159 
4.11 Costing 
We attempted to provide perspective on the potential economic fallout of AKI by 
determining the government payer health care costs on an individual basis. We tracked 
government payer health care costs over a 30-day period starting on, and inclusive of, the 
index date. We aggregated various costing data using only three sources: 1) inpatient 
hospitalizations from CIHI-DAD, 2) emergency department and dialysis clinic visits 
from CIHI-NACRS, and, 3) physician billings, non-physician billings and lab claims 
from OHIP. This was a conservative approach and did not include several cost sources 
such as same day surgery, medication, rehabilitation, and complex continuing care. CIHI-
DAD and CIHI-NACRS attribute resource intensity weights (RIW) to each individual to 
describe the average amount of hospital resources (administration, staff, supplies, 
technology, equipment, etc.) used by a patient with a particular condition relative to a 
reference patient. RIWs are updated annually. To determine the base RIW, individuals 
are first assigned to a case-mix group according to their most responsible/main diagnoses 
and interventions received. The case-mix groups are further compartmentalized by age 
category. After combining the case-mix group with the corresponding age category, each 
individual’s base RIW is then adjusted to incorporate length of stay and comorbidity 
status.160 The final RIW is multiplied by the hospital-specific cost-per weighted case to 
estimate the individual hospitalization costs for that person. In OHIP, RIWs are not 
applicable. Instead, the unit costs simply represent the fees paid for procedures or 
consultations. All dollar values were harmonized to 2012. 
4.12 Statistical analyses 
We expressed continuous variables as medians (IQR) to account for possible skewed 
distributions and categorical variables as proportions. We used standardized differences 
to evaluate the distribution of covariates between cases and weighted controls after 
matching. To calculate the standardized differences, we took the difference in the means 
of each variable between cases and controls divided by the pooled standard deviation for 
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that variable. In our study, a standardized difference >10% was considered to represent a 
meaningful imbalance between cases and controls.161  
 
We assigned a weight to controls by dividing the number of cases in a matched set 
(always one) over the number of matched controls (one, two, three or four).162 Depending 
on the number of controls in the matched set, possible weights included 1, 0.5, 0.33, or 
0.25. The sum of control weights equaled the case sample size.  
 
To better describe the scope and possible ramifications of AKI in our study, we 
determined the number of unique hospitals that cases presented to along with the 
proportion of cases who received acute dialysis during their hospital encounters. We 
defined receipt of acute dialysis using OHIP feecodes (see Appendix B). We further 
categorized cases by the top ten most responsible (CIHI-DAD) /main (CIHI-NACRS) 
diagnoses.  
 
We used several statistics to describe the underlying daily maximum temperatures and 
daily maximum humidexes represented by the 95th percentiles in our sample of cases and 
controls. We used ArcGIS software to map the daily maximum actual temperature 
corresponding to the 95th percentile across all the 19,094 DAs for which GEM-SURF 
data were available in Ontario. 
 
We performed conditional logistic regression to estimate unadjusted and adjusted ORs 
along with 95% CIs. We chose conditional logistic regression specifically to account for 
correlation within matched sets. The adjusted analyses included all variables listed in 
Section 4.9. 
To quantify the effect of our primary analysis in absolute terms, we estimated the 
population incidence rate of AKI in the absence of heat periods. We restricted our focus 
to the warm season of 2012 and filtered through individuals DAs to exclude all dates 
from April 1st, 2012 to September 30th, 2012 that met our definition of a heat period. In 
other words, we combed through all 19,094 DAs to remove dates where on that day and 
the two days prior (lag02) the 95th percentile of area-specific maximum temperature was 
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reached or exceeded. We then linked the list of remaining non-heat dates for each DA to 
RPDB and obtained the number of older adults, 66 years and over, in each dissemination 
area on each non-heat date. We summed the number of persons at risk in each of the DAs 
over all the non-heat period dates to obtain our person-time denominator. Next we 
identified the number of hospital encounters with AKI that occurred over the same list of 
non-heat period dates in the 66 and over population to obtain our numerator. We then 
determined the absolute impact of heat periods on AKI by multiplying our adjusted OR 
estimate (interpreted as RR) by the population incidence rate. We believe this 
approximation was appropriate given the low incidence of AKI observed. Although we 
only sampled controls who remained AKI free at the end of follow-up, rather than 
sampling controls concurrently with cases, the number of older adults omitted from the 
control series was relatively small.163 The rarity of AKI minimized the likelihood of an 
overestimate.164 
4.13 Additional analyses 
To address our third objective, we conducted an analysis stratified by age groups: 
1) those aged 66 to 79 years, and, 2) those over 79 years. We included an interaction term 
in each model to assess whether the age group-specific odds ratios differed. We expected 
to see higher OR estimates in the over 79 group because the elderly are known to be 
vulnerable to environmental heat.34 We formatted the figure for this analysis using R 
software. 
To address our fourth objective, we examined the robustness of the estimates produced 
using our initial matching approach by carrying out a subsequent round of matching. The 
intent of this sensitivity analysis was to control for aspects of location by matching on 
exact DA (inherently controls for residential status and income quintile), sex, age ± 2 
years, age categories (66 to 79 years, over 79 years), and history of CKD. After matching, 
we randomly reselected a new index date for controls to better account for seasonality, 
long-term time trends and autocorrelation in the temperature exposure data. For each 
control, the new index date was on a different date than the matched case, but on the 
same day of week, within the same month, and year. This is a variant of the time-
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stratified method, which has been used extensively for referent selection in previous case-
crossover studies.16–19,33,46,113,144,156,165 We performed exclusions in the control group with 
respect to the new index dates. We did not need to factor the aforementioned time trends 
into our primary analysis because cases and controls were compared on the same date. 
However, we allowed the date to vary in the sensitivity analysis because, otherwise, 
matching on exact DA and index date would result in cases and controls being assigned 
identical exposure sequences. 
We carried out another sensitivity analysis that was restricted to cases in our primary 
cohort and looked at the time of presentation to the emergency department or admission 
to the hospital at lag 0 (index date). The purpose of this analysis was to determine during 
what time of day hospital encounters with AKI were most frequent and to investigate the 
validity of temporality assumptions. Although we were able to definitively conclude that 
daily maximum temperatures at lag 2 and lag 1 preceded the hospital encounters, we did 
not know whether daily maximum temperatures at lag 0 tended to precede the hospital 
encounters. We anticipated that daily maximum temperatures would peak, on average, 
after 12:00 pm. If the majority of cases presented to the hospital after this time we would 
suggest that, in most instances, heat exposure preceded the outcome.  
Lastly, we explored the possibility of overmatching in our primary time-matched 
analyses. To do so, we reduced matched sets by combining case and control groups with 
exactly the same matching factors.166 We then reran the conditional logistic regression 
analyses.  
We conducted all statistical analyses in SAS software version 9.3 (SAS Institute). We 
interpreted two-sided p-values less than 0.05 as statistically significant.  
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Chapter 5 
5 Results 
5.1 Characteristics of cases and controls 
Before matching, we isolated 66,732 cases of AKI and 1,710,783 eligible controls. From 
this population, we matched 53,078 cases to 175,121 controls. After eliminating cases 
and controls who were missing GEM-SURF temperature information, we ended up with 
a total of 52,913 cases matched to 174,222 controls (Figure 4-1 and Figure 4-2). We 
matched 36,424 (69%) cases to four controls, 3,680 (7%) cases to three controls, 4,677 
(9%) cases to two controls and 8,132(15%) cases to one control. We created each 
matched set without any prior knowledge of exposure status.  
Characteristics of cases and weighted controls are presented in Table 5-1. Among both 
cases and controls the median (IQR) age was 80 (74 to 85), 49% were female, 8% were 
classified as having rural residential status, 24% lived in lowest income quintile 
neighborhoods, and 16% had a history of CKD. Cases were more likely than matched 
controls to be diagnosed with diabetes, congestive heart failure, coronary artery disease, 
stroke, peripheral vascular disease, chronic liver disease, and hypertension. Cases were 
also more likely than controls to have evidence of prescriptions for ACE inhibitors alone, 
ARBs alone, both ACE and ARBs together, potassium sparing diuretics, non-potassium 
sparing diuretics, NSAIDs, and psychotropics. Information for all of these variables was 
complete.  
Cases presented to 180 unique hospitals. In total, 2.7% (n=1440) of AKI cases received 
acute dialysis during their hospital encounters. The top five most responsible/main 
diagnoses recorded among cases were acute renal failure (18%), heart failure (6%), other 
septicaemia (5%), other disorders of urinary system (4%), and acute myocardial 
infarction (4%) (Appendix D). The median 30-day government payer health care cost 
among AKI cases was $13,877 (IQR $8,399 to $24,449), compared to a $33 (IQR $0 to 
$135) among controls. 
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5.2 Descriptive characteristics of exposures 
Summary statistics of the 95th percentile thresholds are presented in Table 5-2. 
Aggregating the 227,135 case and control observations in our study, the 95th percentiles 
corresponded to absolute daily maximum actual temperatures as low as 20.1oC and as 
high as 32.5oC, and to absolute daily maximum humidexes as low as 20.1 and as high as 
44.9. The 95th percentiles of daily maximum actual temperatures had an absolute median 
of 30.2oC (standard deviation 1.3oC). The 95th percentiles of daily maximum humidexes 
had an absolute median of 41.7 (standard deviation 2.4).  
Heat periods did not always coincide with high humidex periods. Overall, heat periods 
were moderately to strongly correlated with high humidex periods (Pearson correlation 
coefficient=0.61, p-value<0.0001).  
Figure 5-1 is a map of Ontario depicting the absolute daily maximum actual temperature 
corresponding to the 95th percentile across all of the 19,094 DAs for which data were 
available.  
5.3 Association of acute kidney injury to heat periods and 
high humidex periods 
In our primary analysis, heat periods, compared to non-heat periods, were significantly 
associated with risk of AKI (adjusted OR 1.11, 95% CI 1.00 to 1.23). In our secondary 
analysis, high humidex periods were not significantly associated with risk of AKI 
(adjusted OR 1.04, 95% CI 0.93 to 1.16). The full results from the time-matched cohort 
are displayed in Table 5-3.  
During the 2012 warm season and in the absence of heat periods, we identified 16,071 
AKI events over 355,467,493 person-days at risk. This gives a baseline incidence rate of 
roughly 1,650 cases of AKI per 100,000 person years in the absence of heat periods. 
Therefore the 11% relative increase in risk of AKI associated with heat periods translates 
to approximately 182 additional cases of AKI per 100,000 person-years, taking the warm 
seasons as the time at-risk. 
41 
 
 
5.4 Additional analyses  
We conducted a subgroup analysis to determine whether there was effect modification by 
age group. Contrary to our expectation, the association between heat periods and hospital 
encounters with AKI did not differ across age groups (p-value 0.47). However there was 
a significant difference in the association between high humidex periods and AKI across 
age groups (p-value 0.01), with the association strengthened in those over 79 years. 
Results of the age-stratified analysis are presented in Figure 5-2. 
In our location-matched sensitivity analysis we ended up with 29,904 cases matched to 
60,830 controls (Figure 4-1 and Figure 4-2). The distribution of characteristics for cases 
and controls can be found in Appendix E. In this location-matched sensitivity analysis, 
the adjusted OR for AKI was 1.11 (95% CI 1.00 to 1.23) during heat periods, compared 
to non-heat periods. The adjusted OR for AKI was also elevated during high humidex 
periods compared to non-high humidex periods (adjusted OR 1.20, 95% CI 1.09 to 1.33). 
Results of the sensitivity analysis are displayed in Table 5-4.  
We performed a subsequent sensitivity analysis to investigate what time of day cases 
from our initial cohort were most likely to present to the emergency department or be 
admitted to the hospital with a diagnosis of AKI. We found that on an hourly basis, 
hospital encounters were most frequent between 4:00 pm and 5:00 pm, with the majority 
of cases (n=36,515, 69%) presenting to the hospital after 12:00 pm noon. From these 
results, we would suggest that temporality assumptions were met and that peak heat 
exposure on the index date (lag 0) tended to precede the AKI events. We would further 
stipulate that the remaining patients, who presented to the hospital with AKI before peak 
heat hours (e.g. in the morning), would still have received substantial heat exposure from 
the culmination of the previous two days (lag 1, lag 2) plus whatever time elapsed prior 
to their hospital encounter on the index date (lag 0). We believe this is a reasonable 
conclusion to draw given the high correlation between heat metrics from hour-to-hour. It 
was necessary to carry out this analysis because temporality is a pre-requisite for 
causation. Although we were not able to definitively attribute a causal influence of heat 
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exposure to AKI, the results of this analysis support the possibility of a causal 
connection. 
Collapsing case and control groups to form strata with the same matching criteria did not 
appreciably alter the OR estimates, indicating that the time-matched analyses were not 
subject to overmatching.  
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Table 5-1. Distribution of selected characteristics for AKI cases and controls in 
time-matched analysis 
Variable 
AKI cases1  
(N=52,913) 
Weighted controls1 
(N=52,913) 
Standardized 
differences2 
Demographics 
Age (median, IQR) 80 (74-85) 80 (74-85) 0% 
Over 79 years of age 27,149 (51.3%) 27,149 (51.3%) 0% 
Women 25,688 (48.5%) 25,688 (48.5%) 0% 
Rural residential status3 4,364 (8.2%) 4,364 (8.2%) 0% 
Income quintile4 
  1, low 12,502 (23.6%) 12,502 (23.6%) 0% 
  2 11,639 (22.0%) 11,639 (22.0%) 0% 
  3, middle 9,974 (18.8%) 9,974 (18.8%) 0% 
  4 9,726 (18.4%) 9,726 (18.4%) 0% 
  5, high 9,072 (17.1%) 9,072 (17.1%) 0% 
Comorbid conditions5     
Chronic kidney disease6 8,464 (16.0%) 8,464 (16.0%) 0% 
Diabetes7 23,406 (44.2%) 14,260 (27.0%) 54% 
Congestive heart failure 23,894 (45.2%) 6,302 (11.9%) 116% 
Coronary artery 
disease8 25,557 (48.3%) 13,489 (25.5%) 71% 
Stroke 4,998 (9.4%) 1,490 (2.8%) 41% 
Peripheral vascular 
disease 
2,743 (5.2%) 714 (1.3%) 
32% 
Chronic liver disease 4,755 (9.0%) 1,340 (2.5%) 41% 
Hypertension 44,808 (84.7%) 34,862 (65.9%) 65% 
Medications9 
ACE inhibitors alone 21,772 (41.1%) 14,254 (26.9%) 44% 
ARB alone 10,531 (19.9%) 7,943 (15.0%) 19% 
ACE inhibitors and 1,907 (3.6%) 847 (1.6%) 18% 
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ARB use 
Potassium-sparing 
diuretics 6,727 (12.7%) 2,189 (4.1%) 46% 
Nonpotassium-sparing 
diuretics 31,584 (59.7%) 17,206 (32.5%) 83% 
NSAIDs, excluding 
aspirin 8,407 (15.9%) 5,880 (11.1%) 21% 
Psychotropics10 11,258 (21.3%) 5,549 (10.5%) 44% 
Abbreviations: ACE, angiotensin-converting enzyme; AKI, acute kidney injury; ARB, angiotensin II 
receptor blocker; IQR, interquartile range; N, number; NSAID, non-steroidal anti-inflammatory drug  
1 Data are presented as number (%) of individuals, unless otherwise stated  
2 Standardized differences were derived by taking the difference in means between cases and weighted 
controls over the pooled standard deviation. Standardized differences are less sensitive to sample size 
compared to traditional hypothesis tests. Standardized differences > 10% were considered to represent 
meaningful imbalances between cases and controls.  
3 All residential areas where the community size was ≤10,000 individuals were classified as rural. 
4 Income was categorized into fifths of average neighborhood income, with 1 indicating the lowest 
(poorest) quintile and 5 the highest (richest) quintile on a relative scale.  
5 With the exception of diabetes, all other comorbidities were assessed using diagnostic, procedural, and/or 
fee codes logged in administrative databases in the five years prior to index date.  
6 In Ontario, positive coding algorithm for detecting chronic kidney disease identifies older adults with 
median (IQR) eGFR of 38 mL/min per 1.73 m2 (26 to 51); its absence identifies those with a median (IQR) 
eGFR of 69 mL/min per 1.73 m2 (56 to 82). 167 
7 Diabetes was defined using the Ontario Diabetes Database (ODD), which contains records on all Ontario 
diabetic patients identified since 1991.  
8 Coronary artery disease excluded diagnoses of angina.   
9 Medication use was assessed in the 120 days prior to index date.  
10 Psychotropics included antidepressants (selective-serotonin reuptake inhibitors, serotonin-norepinephrine 
reuptake inhibitors) and antipsychotic medications. 
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Table 5-2. Descriptive statistics of 95th percentile of daily maximum temperature and humidex among AKI cases and controls 
 
Minimum 
Median  
(Percentiles 25th, 75th) Maximum 
Daily maximum temperature (oC) 20.1 30.2 (29.3, 30.7) 32.5 
Daily maximum humidex1 20.1 41.7 (40.8, 42.3) 44.9 
Abbreviations: oC, degrees Celsius 
1humidex = (air temperature in °C) + h. Where h = (0.5555)(E - 10); E= vapour pressure in hPa (mbar), given by: e = 6.11*exp[5417.753*((1/273.16)-(1/dewpoint))] with  
exp = 2.71828. Dewpoint is expressed in kelvins (K) (temperature in K = temperature in °C + 273.16) and 5417.7530 is a rounded constant based on the 
molecular weight of water, latent heat of evaporation, and the universal gas constant.168 
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Figure 5-1. Map of 95th percentile of daily maximum temperature by dissemination area in Ontario, June 2004 to April 2013
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Table 5-3. Association of AKI with exposure to heat periods and high humidex periods in time-matched analysis 
Exposure Unadjusted OR (95% CI) Adjusted OR (95% CI)1 
Heat periods2 1.07 (0.98, 1.16) 1.11 (1.00, 1.23) 
High humidex periods3 1.02 (0.93, 1.12) 1.04 (0.93, 1.16) 
Abbreviations: AKI, acute kidney injury; CI, confidence interval; OR, odds ratio 
1 Adjusted for diabetes, congestive heart failure, coronary artery disease excluding angina, stroke, peripheral vascular disease, chronic liver disease, hypertension, 
angiotensin-converting enzyme (ACE) inhibitor use alone, angiotensin II receptor blocker (ARB) use alone, ACE inhibitors and ARBs use together, potassium-
sparing diuretic use, nonpotassium-sparing diuretic use, non-steroidal anti-inflammatory drugs (NSAIDs) use, and psychotropic use. 
2 Heat periods were defined as 3 consecutive days (lag 02) where area-specific daily maximum actual temperature was ≥ 95th percentile, and were compared to all 
periods that did not meet this definition.  
3 High humidex periods defined as 3 consecutive days (lag 02) where area-specific daily maximum humidex was ≥ 95th percentile, and were compared to all 
periods that did not meet this definition. 
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Figure 5-2. Age-based subgroup analyses of association between AKI and exposure to heat periods and high humidex periods 
 
Abbreviations: AKI, acute kidney injury; CI, confidence interval 
Notes: The vertical lines indicate 95% confidence limits. The squares indicate odds ratios. The size of the squares is proportional to the precision of the estimate 
(the square is larger when the 95% CI is narrower). 
1 Adjusted for diabetes, congestive heart failure, coronary artery disease excluding angina, stroke, peripheral vascular disease, chronic liver disease, hypertension, 
angiotensin-converting enzyme (ACE) inhibitor use alone, angiotensin II receptor blocker (ARB) use alone, ACE inhibitors and ARBs use together, potassium-
sparing diuretic use, nonpotassium-sparing diuretic use, non-steroidal anti-inflammatory drugs (NSAIDs) use excluding aspirin, and psychotropic use. 
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Table 5-4. Association of AKI with exposure to heat periods and high humidex periods in location-matched sensitivity analysis 
Exposure Unadjusted OR (95% CI) Adjusted OR (95% CI)1 
Heat periods2 1.08 (0.99, 1.17) 1.11 (1.00, 1.23) 
High humidex periods3 1.14 (1.05, 1.24) 1.20 (1.09, 1.33) 
Abbreviations: AKI, acute kidney injury; CI, confidence interval; OR, odds ratio 
1 Adjusted for diabetes, congestive heart failure, coronary artery disease excluding angina, stroke, peripheral vascular disease, chronic liver disease, hypertension, 
angiotensin-converting enzyme (ACE) inhibitor use alone, angiotensin II receptor blocker (ARB) use alone, ACE inhibitors and ARBs use together, potassium-
sparing diuretic use, nonpotassium-sparing diuretic use, non-steroidal anti-inflammatory drugs (NSAIDs) use, and psychotropic use. 
2 Heat periods were defined as 3 consecutive days (lag 02) where daily maximum actual temperature was ≥ 95th percentile, and were compared to all periods that 
did not meet this definition.  
3 High humidex periods defined as 3 consecutive days (lag 02) where daily maximum humidex was ≥ 95th percentile, and were compared to all periods that did 
not meet this definition. 
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Chapter 6 
6 Discussion 
6.1 Overview of findings 
This population-based, matched case-control study adds to the growing body of evidence 
supporting a link between environmental heat and AKI risk in older adults. To our 
knowledge, it is one of the first studies to find evidence of this association in Ontario, 
Canada. Our primary results showed that AKI risk was positively associated with three-
day relative heat periods (adjusted OR 1.11, 95% CI 1.00 to 1.23), compared with three-
day non-heat periods. As hypothesized, our sensitivity analysis reinforced this estimate 
(adjusted OR 1.11, 95% CI 1.00 to 1.23). The magnitude of our estimates for heat periods 
broadly parallel previous findings.105, 109 Confirmation of this association strengthens our 
hypothesis that this is a true effect.  
The main effect of high humidex periods was more difficult to resolve. Only high 
humidex periods, and not heat periods, showed a significant interaction effect by age 
group. Compared to those aged 66 to 79 years, those over 79 years of age were at 
increased risk of humidex-associated AKI. This is in line with past research documenting 
impaired heat tolerance in the elderly.34 
Our decision to define heat periods and high humidex periods by the 95th percentile 
corresponds well with Environment Canada’s thresholds for issuing heat alerts. In 
Southern Ontario a heat alert may be declared when over two consecutive days the daily 
maximum temperature is expected to be ≥31oC and nighttime minimum temperature is 
expected to be ≥20oC, or, when the daily maximum humidex is expected to be ≥40.28 In 
Northern Ontario the thresholds are reduced to a daily maximum temperature of ≥29oC 
and nighttime minimum temperature of ≥16oC, or, a daily maximum humidex ≥36.28 
Extreme heat alerts use the same thresholds sustained over three or more days.28 In our 
work, the overall median of the 95th percentile of maximum daily temperature was 
30.2oC. The overall median of the 95th percentile of maximum daily humidex was 41.7. 
This demonstrated that our exposure indicators actually represented high heat.  
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By using percentiles in our work, we were able to apply a single definition of heat that 
accounted for the relative experience of temperature across geographic locations in the 
same way that Environment Canada uses multiple different thresholds for different parts 
of Ontario. For example, the 95th percentile of daily maximum temperature in a remote 
northern DA may have represented a raw reading of 28oC. Among individuals living in 
this northern DA, 28oC would be a manifestation of heat compared to the temperatures 
they typically experienced. In contrast, the 95th percentile of daily maximum temperature 
in a more southern DA may have represented a raw reading of 31oC. Since this DA was 
consistently hotter, it would follow that individuals living there would possess greater 
adaptive mechanisms for dealing with heat and would be more likely to experience AKI 
at 31oC than at 28oC. In summary, heat thresholds differed by region as a function of the 
local climate along with the physiological and behavioral acclimation of residents. 
6.2 Implications 
The adjusted OR estimates in this study were quite small. However, our method of 
detecting AKI lacked sensitivity and incidence may have been underestimated by up to 
five-fold. In absolute terms, we approximated that heat periods associated with an 
additional 182 cases of AKI per 100,000 person years during the warm seasons. 
Considering the median 30-day government payer health care costs for a single AKI case 
was $13,877, the costs of treating 182 cases of AKI may conceivably surpass $2.5 
million CDN. With the average yearly temperature in Ontario projected to increase 
another 2.3oC by the 2020s and as much as 4.1oC by the 2050s,169 it is probable that more 
Ontario residents will soon be exposed to heat periods.  
Heat-associated AKI can be averted, should the appropriate preventative measures be put 
in place. To this end, air conditioning is one of the top protective interventions in 
combatting the effects of environmental heat.66 During times of extreme heat the 
provision of sufficient air-conditioned spaces, at community centers and other public 
institutions, is pertinent.170 Increased transportation and extended operating hours to these 
spaces is also recommended to facilitate accessibility. The city of Toronto, Ontario is a 
good use case for why public cooling stations should be provided. In a survey that 
included 184 residents, roughly half reported limiting their household use of air 
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conditioners, citing costly energy bills as a limiting factor.171 Residents who choose not 
to run their air conditioners, or who do not have access, may further exacerbate their risk 
by improper usage of electric fans. Turning on a fan while the windows are closed, and 
without intermittent air conditioning, simply recirculates hot air. This hinders radiative 
and conductive heat loss and can hasten the process of dehydration. 
Based on past research, the operational costs of running heat alert response programs are 
minimal relative to the savings gained from effective prevention of heat-related morbidity 
and mortality.172 A similar conclusion may be intuited from our results. The dollar values 
we have reported do not encompass the social and emotional costs of having an AKI 
event. Therefore coordinating announcements of heat warnings appears to be a promising 
economic endeavor though more research is needed to confirm cost-effectiveness. 
In order to maximize the effectiveness of heat warnings, outreach strategies and 
messaging should be targeted to vulnerable groups.173 Taking our findings under 
consideration, educational content on heat-related AKI may be particularly impactful 
when framed for community-dwelling seniors. These individuals, who have retained their 
independence, may be inclined to envisage themselves as resilient to heat despite 
evidence to the contrary.174 An interview-based study of subjects aged 72 to 94 found 
respondents generally recognized the elderly as vulnerable, though they did not perceive 
themselves as elderly or vulnerable.175 Interestingly, the behavior of medical caregivers 
may play into this misperception. An investigation of nursing home patients during the 
2003 heat wave in France, demonstrated that the mortality rate in less dependent patients 
was 8.3 times higher during the heat wave compared to before, but only 3.9 times higher 
in the most dependent patients.176 The authors hypothesized that medical staff may have 
been more prone to administer interventions to the highly dependent patients, thereby 
preferentially preventing deaths in this group during the heat wave.176 The impartial focus 
on the most dependent elderly patients may propagate erroneous beliefs that less 
dependent elderly patients are immune to the negative impacts of heat. These narratives 
of independence are persuasive and it is important that attitudes of autonomy and a lack 
of knowledge regarding heat do not continue to amplify risk in the elderly population.  
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Moving forward, educating the community-dwelling elderly on relevant heat-coping 
strategies in a manner that does not undermine their independence should be a priority. 
The educational content should stress the short-latency period of the proposed heat and 
AKI association while emphasizing protective measures like air conditioning, increased 
fluid intake, and avoidance of outdoor physical exertion. It is critical that this educational 
content also be aimed at caregivers and physicians so that they too understand and can 
discuss the AKI health risks with their patients.24,177 
6.3 Implications of the selected study design 
Considering our objectives and data constraints, we believe that the case-control design 
was an efficient choice in comparison to a cohort-design.178 The case-control design is 
tailored to explore individual associations between a single outcome and multiple 
exposures using external controls. Furthermore, the large administrative databases at 
ICES enabled us to identify a sufficient number of cases to examine associations with 
precision. However, we do acknowledge that case-control studies are prone to selection 
bias. We attempted to reduce this bias by selecting cases and controls independent of our 
exposures of interest.  
In the literature, time-series21,143,145–149,155,165,179 and case-crossover16–19,33,46,69,113,144,156,165 
designs predominate. However, we did not feel that either approach was ideally suited to 
our purposes.  
Contemporary time-series analyses employ distributed lag non-linear models (DLNM). 
When using the DLMN framework, outcome data are summed into daily-counts which 
are treated as originating from an overdispersed Poisson distribution.180 Like the name 
suggests, DLNMs are ideal for modeling the lagged structure of temperature-health 
associations. In our study, the temporal delay was not a principal concern as we decided 
to focus on a fixed three-day lag. The decision to stick with a single lag dimension was 
guided by clinician expertise and findings from prior investigations.22,33,113,146 Another 
reason we chose to forgo the use of DLNMs was because we foresaw numerous problems 
with model convergence and wished to avoid performing case-only analyses. DLNMs 
have been designed to be very flexible, with several mutable parameters. As a direct 
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consequence, the inferences made from DLNMs may be conditional on post-hoc 
selection of the best model fit. The standard practice has been to use DLNMs to obtain 
area-specific risk estimates that can then be meta-analyzed to form an overall estimate. 
Given the sheer number of possible DAs in the GEM-SURF database (19,094) and the 
small number of cases within each, if applied to our work, this methodology would likely 
have yielded issues with subjectivity, data suppression, and unreliable estimates.  
In the case-crossover design each case serves as its own control. The design is 
advantageous in that it accounts for all known and unknown confounding factors that do 
not change with time.181 However, selecting referent days to compare exposures across 
the same individual can be problematic. Sampling referents bidirectionally, both before 
and after case events, achieves substantial reductions in bias from trends in the 
exposure.182 Yet, the bidirectional sampling scheme is plagued by the assumption that 
case events will not be repeated and that having an event will not influence subsequent 
exposures.183 We were not prepared to make these assumptions as AKI is a repeatable 
event and in many circumstances, the occurrence of AKI would likely have modified 
subsequent behavior of the afflicted individuals. In our sensitivity analysis, we avoided 
the need to make these assumptions by adapting the time-stratified referent selection 
strategy of case-crossover studies to a set of external controls. We then used matching 
techniques and multivariable adjustment to control for inter-individual variation.  
6.4 Strengths 
One strength of our study was focusing on the single outcome of AKI. We deliberately 
prespecified our analyses to avoid an inflated type 1 error rate stemming from multiple 
comparisons.  
Another strength of our study was the use of microscale weather data. We capitalized on 
the granularity of GEM-SURF temperature readings by matching cases and controls on 
the exact same index date. By comparing matched cases and controls on the same date, 
our primary analysis controlled for seasonality, long-term trends, and autocorrelation in 
the exposure series. This circumvented the need for more complicated adjustment 
approaches that may have introduced error.111 Matching on index date has not been 
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possible in the past due to the reliance on weather station data that outputs uniform 
temperature readings across expansive geographic regions. For example, in prior studies 
data from the weather station at Pearson International Airport has been extrapolated to 
cover all of Toronto.  
By confining our analysis to the older adult population (66 years and over), we ensured 
that personal medication histories could be included as control variables in our models. 
Although this age restriction curtailed generalizability, it strengthened our study because 
many drugs are known to increase heat-susceptibility and the risk of AKI through 
alterations in fluid balance.34,36,184 Previous investigations that provided area-level 
estimates were unable to incorporate information on personal medication histories.22,147 
While other investigations that used case-crossover designs to provide individual-level 
estimates also tended to omit information on personal medication histories, implicitly 
assuming that there was no intra-individual variation. Seeing as medication use does vary 
with time, this assumption may not have been entirely valid.  
6.5 Limitations 
The dependence on ecological exposure data is a shared limitation of ambient 
temperature studies. Traditionally, ecological temperatures were designated to individuals 
by mapping the individuals’ residential postal codes to the nearest weather 
stations.16,18,19,113 In an effort to minimize misclassification bias, this process was often 
extended to create circular buffers with pre-specified radial distances (e.g. 10 kilometers) 
around each weather station. Only individuals for whom the geographic centroid of their 
residential postal code fell within the buffers were included. Even with these safeguards 
in place, it is probable that variable activity patterns introduced exposure error. The same 
holds true in our study. Although we used GEM-SURF spatial models to provide more 
targeted exposure data, temperature assignation was still done ecologically at the level of 
the DA. We had no individual-level data on air conditioning use and work-leisure 
schedules, both of which may have impacted heat exposure.19  
To assign DAs, we used residential postal codes as opposed to hospital postal codes 
because we wanted to apply a uniform technique of converting postal codes to 
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geographic areas. Both cases and controls had residential postal codes listed in the RPDB 
database, while only cases had applicable hospital postal codes. Inaccuracies may have 
resulted from using the residential postal codes, as individuals do not always report 
changes in addresses and do not always reside full-time at their primary addresses, 
especially during the summer. The inaccuracies may have been most pronounced in the 
controls. We would stipulate that controls were more likely than cases to leave their 
primary dwellings as they were generally in better health. Future studies may benefit 
from selecting controls with evidence of hospital encounters for conditions unrelated to 
AKI. This would minimize exposure misclassification by enabling hospital postal codes 
to be used uniformly for temperature assignation while simultaneously obviating the need 
to randomly select index dates for the controls series. 
Our study may also be limited by inappropriate geographic boundary selection 23 DAs are 
defined for administrative uses and respect the boundaries of larger geographic units such 
as census subdivisions and census tracts. They also vary considerably in physical size and 
tend to be much larger in the north. Differences in temperature recorded between 
neighboring grid points, or DAs, may be somewhat distorted particularly at the edges 
where the DAs meet.185 We did not compensate for the possibility of edge effects.  
Another limitation of our study is the heavy reliance on routinely collected administrative 
data, which are not primarily intended for research purposes. When drawing together 
information on covariates to adjust for, we were restricted to certain types of data, mainly 
diagnostic codes, fee codes, and procedural codes. Our retrospective data sources did not 
contain information on some proposed risk factors for heat-related AKI like exercise-
exertion and water intake.  
We lost a substantial number of cases during matching. It is possible that the distribution 
of characteristics in these unmatched cases differs with respect to our matched cases. 
Thus, the representativeness of our selected population remains in question.  
Lastly, we failed to capture AKI events that did not result in a hospital encounter, 
including out-of-hospital deaths. It is possible that our associations would have been 
57 
 
 
strengthened had we had individual-level exposure information and more sensitive 
outcomes measures.  
6.6 Conclusion and future directions 
AKI is a serious health complication. In accordance with previous work, the results of our 
study suggest that AKI is positively associated with heat periods among older adults. 
However, we cannot dismiss the possibility of residual confounding or the influence of 
unmeasured confounders such as occupation26 and mental health.49,186 Up to this point, 
inconsistent study designs and varied definitions of what comprises heat have inhibited 
evidence synthesis. Rigorous methods, such as the implementation of percentiles to 
quantify temperature on a transferable scale, are needed to support cross-investigation 
comparisons. Whether to select geographic-varying exposures over time-varying 
exposures as the optimal methodological approach also necessitates further research. The 
generalizability of the heat and AKI relationship to broader age ranges warrants 
investigation, as do the specific mechanisms underlying heat-related AKI. Incorporating 
laboratory information (SCr) may aid in these endeavors by improving identification of 
AKI events. Randomized controlled trials testing the efficacy of mitigation strategies 
should also be considered. Knowledge of the types of interventions that are needed (e.g. 
heat alerts, cooling stations), for whom, and at what regional level is required to inform 
policy decisions and public health planning. 
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Appendices 
Appendix A: Definitions of preliminary exclusions 
Variable Database(s) Code(s) 
Dialysis in the year prior 
to index date. This 
includes any dialysis 
modality (e.g. acute, 
chronic, access creation).  
CIHI-DAD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ICD-9: V451, V560, V568, 99673 
ICD-10: T824, Y602, Y612, Y622, 
Y841, Z49, Z992 
CCP: 5127, 5142, 5143, 5195, 6698 
CCI: 1PZ21, 1OT53DATS, 
1OT53HATS, 1OT53LATS, 
1SY55LAFT, 7SC59QD, 1KY76, 
1KG76MZXXA, 1KG76MZXXN, 
1JM76NC, 1JM76NCXXN 
 OHIP OHIP feecodes: R850, G324, G336, 
G327, G862, G865, G099, R825, 
R826, R827, R833, R840, R841, 
R843, R848, R851, R946, R943, 
R944, R945, R941, R942, Z450, 
Z451, Z452, G864, R852, R853, 
R854, R885, G333, H540, H740, 
R849, G323, G325, G326, G860, 
G863, G866, G330, G331, G332, 
G861, G082, G083, G085, G090, 
G091, G092, G093, G094, G095, 
G096, G294, G295 
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Kidney transplant in the 
five years prior to index 
date.  
CIHI-DAD  
OHIP  
CCI: 1PC85 
OHIP feecodes: S435, S434 
Long-term care facility 
utilization 
ODB 
 
Looked at most recent ODB 
prescription prior to index date for 
long-term care flag.  
Abbreviations: CCI, Canadian Classification of Health Interventions; CCP Canadian Classification of 
Diagnostic, Therapeutics, and Surgical Procedures; CIHI-DAD, Canadian Institute for Health Information 
Discharge Abstract Database; dx, diagnosis; ICD-9 International Classification of Diseases, ninth revision; 
ICD-10, International Classification of Diseases, tenth revision; ODB, Ontario Drug Benefit database; 
OHIP, Ontario Health Insurance Plan claims database.  
Note: Prior to 2002, diagnostic codes followed ICD-9 and procedural codes followed CCP. From 2002 
onward, diagnostic codes followed ICD-10 and procedural codes followed CCI. ICD-9 and ICD-10 were 
developed by the World Health Organization. CCP and CCI were developed by CIHI.    
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Appendix B: Definitions of outcomes 
Variable Database(s) Code(s) 
Acute kidney injury  CIHI-DAD,  
NACRS 
ICD-10: N17 
Receipt of acute 
dialysis 
 
OHIP OHIP feecodes: R849, G323, G866, 
G330, G331, G093, G095, G294, 
G295 
Abbreviation: CIHI-DAD, Canadian Institute for Health Information Discharge Abstract Database; ICD-
10, International Classification of Diseases, tenth revision; Ontario Health Insurance Plan claims database; 
NACRS, National Ambulatory Care Reporting System database 
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Appendix C: Definitions of demographic variables and comorbid conditions  
Variable Database(s) Code(s) 
Age RPDB  
Sex RPDB  
Annual postal code of 
residence 
 
RPDB Best known postal code for eligible 
RPDB person on July 1st each year. 
Drew from previous census data and 
information collected each time a 
person makes contact with a health 
care institution. 
Residential status  CENSUS   
Neighbourhood income 
quintile 
CENSUS  
Chronic kidney disease  CIHI-DAD 
 
 
 
 
OHIP  
ICD-9: 4030, 4031, 4039, 4040, 4041, 
4049, 585, 586, 5888, 5889, 2504 
ICD-10: E102, E112, E132, E142, I12, 
I13, N08, N18, N19 
OHIP dx: 403, 585 
Diabetes  ODD  
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Congestive heart failure 
 
CIHI-DAD 
 
 
 
ICD-9: 425, 5184, 514, 428 
ICD-10: I500, I501, I509, I255, J81 
CCP: 4961, 4962, 4963, 4964 
CCI: 1HP53, 1HP55, 1HZ53GRFR, 
1HZ53LAFR, 1HZ53SYFR 
 OHIP 
 
OHIP feecodes: R701, R702, Z429 
OHIP dx: 428 
Coronary artery disease  CIHI-DAD 
 
 
 
 
ICD-9: 412, 410, 411 
ICD-10: I21, I22, Z955, T822 
CCI: 1IJ50, 1IJ76 
CCP: 4801, 4802, 4803, 4804, 4805, 
481, 482, 483 
 OHIP OHIP feecodes: R741, R742, R743, 
G298, E646, E651, E652, E654, E655, 
Z434, Z448 
OHIP dx: 410, 412 
All stroke CIHI-DAD 
 
ICD-9: 430, 431, 432, 434, 435, 436, 
3623 
ICD-10: I62, I630, I631, I632, I633, 
I634, I635, I638, I639, I64, H341, 
I600, I601, I602, I603, I604, I605, 
I606, I607, I609, I61, G450, G451, 
G452, G453, G458, G459, H340 
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Peripheral vascular 
disease 
CIHI-DAD 
 
 
 
 
 
ICD-9: 4402, 4408, 4409, 5571, 4439, 
444 
ICD-10: I700, I702, I708, I709, I731, 
I738, I739, K551 
CCP: 5125, 5129, 5014, 5016, 5018, 
5028, 5038, 5126, 5159 
CCI: 1KA76, 1KA50, 1KE76, 1KG50, 
1KG57, 1KG76MI, 1KG87, 
1IA87LA, 1IB87LA, 1IC87LA, 
1ID87, 1KA87LA, 1KE57  
 OHIP OHIP feecodes: R787, R780, R797, 
R804, R809, R875, R815, R936, 
R783, R784,R785, E626, R814, R786, 
R937, R860, R861, R855, R856, 
R933, R934, R791, E672, R794, 
R813, R867, E649 
Chronic liver disease CIHI-DAD 
 
 
 
ICD-9: 4561, 4562, 070, 5722, 5723, 
5724, 5728, 573, 7824, V026, 2750, 
2751, 7891, 7895, 571 
ICD-10: B16, B17, B18, B19, I85, 
R17, R18, R160, R162, B942, Z225,  
E831, E830, K70, K713, K714, K715, 
K717, K721, K729, K73, K74, K753, 
K754, K758, K759, K76, K77 
 OHIP OHIP dx: 571, 573, 070 
OHIP feecodes: Z551, Z554 
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Hypertension CIHI-DAD 
 
ICD-9: 401, 402, 403, 404, 405 
ICD-10: I10, I11, I12, I13, I15 
 OHIP OHIP dx: 401, 402, 403 
Abbreviations: CCI, Canadian Classification of Health Interventions; CCP Canadian Classification of 
Diagnostic, Therapeutics, and Surgical Procedures; CIHI-DAD, Canadian Institute for Health Information 
Discharge Abstract Database; dx, diagnosis; ICD-9 International Classification of Diseases, ninth revision; 
ICD-10, International Classification of Diseases, tenth revision; ODB, Ontario Drug Benefit database; 
ODD, Ontario Diabetes Database; OHIP, Ontario Health Insurance Plan claims database; RPDB, 
Registered Persons Database 
Note: Prior to 2002, diagnostic codes followed ICD-9 and procedural codes followed CCP. From 2002 
onward, diagnostic codes followed ICD-10 and procedural codes followed CCI. ICD-9 and ICD-10 were 
developed by the World Health Organization. CCP and CCI were developed by CIHI.    
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Appendix D: Top ten main/most responsible diagnoses among AKI cases  
First three 
characters of 
ICD-10 code  
Description Number of cases (%) 
N17 Acute renal failure 9437 (17.8%) 
I50 Heart failure 3299 (6.2%) 
A41 Other septicaemia  2664 (5.0%) 
N39 Other disorders of urinary system 2093 (4.0%) 
I21 Acute myocardial infarction 2083 (3.9%) 
J18 Pneumonia, organism unspecified  1943 (3.7%) 
J44 Other chronic obstructive pulmonary disease 1790 (3.4%) 
Z51 Other medical care 1153 (2.2%) 
E11 Type 2 Diabetes mellitus 1138 (2.2%) 
E86 Volume depletion  681 (1.3%) 
Abbreviations: ICD-10, International Classification of Diseases, tenth revision  
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Appendix E: Distribution of selected characteristics for AKI cases and controls in 
location-matched sensitivity analysis 
Variable 
AKI cases1  
(N=29,904) 
Weighted controls1 
(N=29,904) 
Standardized 
differences2 
Demographics 
Age (median, IQR) 78 (73-84) 78 (73-84) 0% 
Over 79 years of age 13,696 (45.8%) 13,682 (45.8%) 0% 
Women 15,604 (52.2%) 15,604 (52.2%) 0% 
Rural resdience3 2,984 (10.0%) 2,984 (10.0%) 0% 
Income quintile4 
  1, low 7,387 (24.7%) 7,387 (24.7%) 0% 
  2 6,436 (21.5%) 6,436 (21.5%) 0% 
  3, middle 5,628 (18.8%) 5,628 (18.8%) 0% 
  4 5,496 (18.4%) 5,496 (18.4%) 0% 
  5, high 4,957 (16.6%) 4,957 (16.6%) 0% 
Comorbid conditions5 
  
Chronic kidney 
disease6 1,554 (5.2%) 1,549 (5.2%) 0% 
Diabetes7 12,937 (43.3%) 7,564 (25.3%) 47% 
Congestive heart 
failure 12,653 (42.3%) 3,013 (10.1%) 97% 
Coronary artery 
disease8 13,902 (46.5%) 7,176 (24.0%) 60% 
Stroke 2,738 (9.2%) 847 (2.8%) 33% 
Peripheral vascular 
disease 1,465 (4.9%) 345 (1.2%) 27% 
Chronic liver disease 2,761 (9.2%) 728 (2.4%) 36% 
Hypertension 25,072 (83.8%) 19,394 (64.9%) 55% 
Medications9 
ACE inhibitors alone 12,264 (41.0%) 7,843 (26.2%) 39% 
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ARB alone 5,915 (19.8%) 4,197 (14.0%) 19% 
ACE inhibitors and 
ARB use  1,049 (3.5%) 398 (1.3%) 17% 
Potassium-sparing 
diuretics 3,739 (12.5%) 1,118 (3.7%) 40% 
Nonpotassium-
sparing diuretics 17,376 (58.1%) 9,257 (31.0%) 70% 
NSAIDs, excluding 
aspirin 5,022 (16.8%) 3,466 (11.6%) 18% 
Psychotropics10 6,691 (22.4%) 3,581 (12.0%) 34% 
Abbreviations: ACE, angiotensin-converting enzyme; AKI, acute kidney injury; ARB, angiotensin II 
receptor blocker; IQR, interquartile range; N, number; NSAID, non-steroidal anti-inflammatory drug  
1 Data are presented as number (%) of individuals, unless otherwise stated  
2 Standardized differences were derived by taking the difference in means between cases and weighted 
controls over the pooled standard deviation. Standardized differences are less sensitive to sample size 
compared to traditional hypothesis tests. Standardized differences >10% were considered to represent 
meaningful imbalances between cases and controls  
3 All areas where the community size was ≤10,000 individuals were classified as rural. 
4 Income was categorized into fifths of average neighborhood income, with 1 indicating the lowest 
(poorest) quintile and 5 the highest (richest) quintile.  
5 With the exception of diabetes, all other comorbidities were assessed using diagnostic, procedural, and/or 
fee codes logged in administrative databases in the five years prior to index date.  
6 In Ontario, positive coding algorithm for detecting chronic kidney disease identifies older adults with 
median (IQR) eGFR of 38 mL/min per 1.73 m2 (26 to 51); its absence identifies those with a median (IQR) 
eGFR of 69 mL/min per 1.73 m2 (56 to 82). 167 
7 Diabetes was defined using the Ontario Diabetes Database, which contains records on all Ontario diabetic 
patients identified since 1991. 
8 Coronary artery disease excluded diagnoses of angina.   
9 Medication use was assessed in the 120 days prior to index date.  
10 Psychotropics included antidepressant (selective-serotonin reuptake inhibitors, serotonin-norepinephrine 
reuptake inhibitors) and antipsychotic medication. 
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